SCHEMBL4353170

SCHEMBL4353170

Cc1c(Cl)cc(N(S)C(=O)Nc2cc(Cl)cc(Cl)c2)c(O)c1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
GAA P10253 1/20 0.36
P2RY1 P47900 1/20 0.35
MEN1 O00255 3/20 0.34
MAPT P10636 3/20 0.34
KMT2A Q03164 3/20 0.34
NPSR1 Q6W5P4 2/20 0.34
RAB9A P51151 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
P2RX1 P51575 1/20 0.34
P2RX4 Q99571 1/20 0.34
P2RX7 Q99572 1/20 0.34
TMPRSS4 Q9NRS4 1/20 0.34
GRM4 Q14833 2/20 0.33
JUN P05412 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
DHODH Q02127 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345478 0.88 TSHR (0.47) ALDH1A1GAAMEN1MAPTKMT2A
SCHEMBL4349377 0.86 EGFR (0.41) ALDH1A1GAAMEN1MAPTKMT2A
SCHEMBL4346893 0.82 PTGS1 (0.41) ALDH1A1GAAP2RY1MEN1MAPT
SCHEMBL4347869 0.81 MTOR (0.43) MEN1MAPTKMT2ARAB9AP2RX1
SCHEMBL4357681 0.76 KMT2A (0.36) ALDH1A1GAAP2RY1MEN1MAPT
SCHEMBL4354035 0.76 MEN1 (0.42) ALDH1A1GAAP2RY1MEN1MAPT
SCHEMBL4350861 0.75 ALDH1A1 (0.38) ALDH1A1GAAP2RY1MEN1MAPT
SCHEMBL4342472 0.75 P2RY1 (0.41) ALDH1A1P2RY1MEN1MAPTKMT2A
SCHEMBL4357779 0.74 HTT (0.43) ALDH1A1GAAMEN1MAPTKMT2A
SCHEMBL4357522 0.73 POLB (0.33) ALDH1A1MAPTNPSR1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
WO-2004030664-A2 NEW COMPOUNDS FOR THE INHIBITION OF UNDESIRED CELL PROLIFERATION AND USE THEREOF JERINI AG (DE) 2004-04-15 WO claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885GAA 4010/4885P2RY1 3208/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885GAA 3384/4885P2RY1 3254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.